Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression-Reference-Cited by-同舟云学术

Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression

Published:2015-10-19 Issue:11 Volume:21 Page:1337-1343
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Alam Muhammad S,Gaida Matthias M,Bergmann Frank,Lasitschka Felix,Giese Thomas,Giese Nathalia A,Hackert Thilo,Hinz Ulf,Hussain S Perwez,Kozlov Serguei V,Ashwell Jonathan D

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.3957.pdf

Reference38 articles.

1. Neesse, A. et al. Stromal biology and therapy in pancreatic cancer. Gut 60, 861–868 (2011).

2. Coussens, L.M., Zitvogel, L. & Palucka, A.K. Neutralizing tumor-promoting chronic inflammation: a magic bullet? Science 339, 286–291 (2013).

3. Mantovani, A., Allavena, P., Sica, A. & Balkwill, F. Cancer-related inflammation. Nature 454, 436–444 (2008).

4. Grivennikov, S.I., Greten, F.R. & Karin, M. Immunity, inflammation and cancer. Cell 140, 883–899 (2010).

5. Salvador, J.M. et al. Alternative p38 activation pathway mediated by T cell receptor–proximal tyrosine kinases. Nat. Immunol. 6, 390–395 (2005).

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TNFR1 signaling promotes pancreatic tumor growth by limiting dendritic cell number and function;Cell Reports Medicine;2024-08

2. The PIN1-p38-CtIP signaling axis protects stalled replication forks from deleterious degradation;2024-06-26

3. Current and future immunotherapeutic approaches in pancreatic cancer treatment;Journal of Hematology & Oncology;2024-06-04

4. How We Got Here: One Laboratory's Odyssey in the Field of Radiation-Inducible Genes;Radiation Research;2024-04-04

5. LSINCT5: A Novel lncRNA in Cancers;Current Medicinal Chemistry;2023-12